Business Performance Review of three FTSE Stocks: ITM, CRW & TED

Business Performance Review of three FTSE Stocks: ITM, CRW & TED

ITM Power Plc

ITM Power Plc (LON: ITM) shapes and produces unified hydrogen power solutions to boost the consumption of renewable power that would otherwise be wasted. It generates hydrogen gas based on Proton Exchange Membrane technology. This technology utilises renewable electricity and collects water to create hydrogen gas on-site and has a product which can be utilized at exceeding 100 megawatts in operations. It is an internationally accepted specialist company in hydrogen technologies with the governing principle to take additional energy from the power network and transform it into hydrogen and use it in one of three broad market areas – Power-to-X, Industry and Mobility.

ITM - News Updates

On 27th December 2019, the company announced that 10,000 options over ordinary shares in the company have been exercised by an employee. On 29th April 2010, the options were granted at an exercise price of 24.25 pence. Now, the company’s issued share capital comprises of 471.3 million ordinary shares with one voting right per share and no shares held in treasury.

On 5th December 2019, the company announced that Graham Cooley and Simon Bourne have sold the resultant holdings of 1.0 million and 0.2 million shares for £0.6178 per share whereas Rachel Smith sold enough of her resultant holdings of 0.035 million shares for £0.6785 per share.

ITM – Financial Highlights

On 03rd December 2019, the company announced its full-year results for the year ended 30th April 2019.

The total revenue & grant funding increased to £17.5 million in FY2019 versus £14.1 million in FY2018, a change of 24.1%. The gross loss increased to £1.2 million in FY2019 versus £0.16 million in FY2018. The operational loss increased to £9.3 million in FY2019, an increase of 44% as compared to the previous year. The EBITDA loss of £7.5 million increased 56% in FY2019 as compared to the last year due to investment to substantially scale up services capability, production capacity and resources.

The available company cash was reported at £5.2 million at the financial year-end. However, the company announced to raise fund of minimum of £52 million through placement of equity which includes £38 million cornerstone investment from brand new strategic partner Linde Engineering; £14 million firm placement with certain existing and new institutional investors and open offer of around £6.8 million.

The non-contracted tender opportunity pipeline improved to more than £379 million in FY2019. The Hydrogen fuel agreements increased to 33 in FY2019 as compared to 20 in FY2018 with fuel sales increasing to 32 tonnes in FY2019 versus 16 tonnes in FY2018, a change of 100%.

ITM – Share Price Performance

On 03rd January 2020 as at 09:57 AM GMT, the ITM share price was trading at GBX 78.64 per share on the London Stock Exchange, a decrease of 2.91 per cent or GBX 2.36 per share, versus previous day’s closing price of GBX 81.0 per share.

The share price of GBX 82.0 was the 52-week peak price as on 03rd January 2020, whereas the share price of GBX 18.44 was the 52-week low share price as on 05th February 2019. The current share price was lower by 4.09 per cent from the 52-week high price, whereas it was higher by 326.46 per cent from the 52-week low price.

The company’s market capitalisation was reported at GBP 336.06 million at the time of writing. The free float and share outstanding of the ITM were reported at 236.42 million and 471.32 million, respectively.

While writing, the beta of the ITM share was stated at 0.40, which shows lower volatility as compared to the benchmark market index’s movement.

Craneware Plc

Craneware Plc (LON: CRW) is a UK based company which was founded in the year 1999.  The company launched the original & initial automatic chargemaster management solution for the healthcare sector of the USA. Since 1999, the company has a partnership with various hospitals and healthcare systems throughout the nation to assist in enhancing and maintaining financial performance. The company is the market frontrunner in Value Cycle solutions for the healthcare market of the US.

CRW - News Updates

On 23rd December 2019, the company announced that CEO of the company, Keith Neilson exercised options over 10,332 ordinary shares of 1 pence each at an exercise price of 335 pence per ordinary share. Now Neilson holds 3.39 million ordinary shares in the capital of the company which represents 12.7% of issued share capital.

On 29th November 2019, the company declared the news regarding its final dividend which was announced on 3rd September 2019. The company said that shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.29 per Pound.

CRW – Financial Highlights

On 03rd September 2019, the company announced its audited results for the year ended 30th June 2019.

The revenue rose by 6 per cent to $71.4 million in FY2019 versus $67.1 million in FY2018. The adjusted EBITDA increased by 11% to $24.0 million in FY2019 versus $21.6 million in FY2018. Profit before tax decreased to $18.3 million in FY2019 versus $18.9 million in FY2018 due to $1.2 million one-off costs connected to a substantial proposed acquisition.

The basic adjusted EPS increased by 5% to $0.633 in FY2019 versus $0.602 in FY2018 and adjusted diluted EPS increased to $0.620 in FY2019 versus $0.591 in FY2018. The cash was reported at $47.6 million as at 30th June 2019 versus $52.8 million as at 30th June 2018 after having returned $8.5 million to investors via dividends.

The proposed final dividend rose to 19.05 U.S. cents in FY2019 versus 18.48 U.S. cents in FY2018.

CRW – Share Price Performance

On 03rd January 2020 as at 09:57 AM GMT, the CRW share price was trading at GBX 2,456 per share on the London Stock Exchange, an increase of 2.55 per cent or GBX 61.0 per share, versus previous day’s closing price of GBX 2,395.0 per share.

The share price of GBX 3,248.0 was the 52-week peak price as on 23rd May 2019, whereas the share price of GBX 1,700.0 was the 52-week low share price as on 08th July 2019. The current share price was lower by 24.38 per cent from the 52-week high price, whereas it was higher by 44.5 per cent from the 52-week low price.

The company’s market capitalisation was reported at GBP 692.12 million at the time of writing. The free float and share outstanding of the CRW were reported at 19.31 million and 26.83 million, respectively.

While writing, the beta of the CRW share was stated at 1.26, which shows higher volatility as compared to the benchmark market index’s movement.

 

Ted Baker Plc

Ted Baker Plc (LON: TED) is a UK-based lifestyle company which is renowned worldwide. Trade baker is one of the best and fastest growing company in its domain, growing from its origin as a single shirt specialist store to international lifestyle brands. The company strategy is to become the world biggest lifestyle brand. In 1988, the company launched its initial store in Glasgow which was swiftly followed by Manchester, Cambridge, Nottingham Exchange Arcade and Sheffield.

TED - Operating Update

On 10th December 2019, the company announced that Rachel Osborne was appointed as CFO in November 2019; Ari Hoffman was appointed as CEO of North America in December 2019, and Peter Collyer was appointed as Chief People Officer and will be joining in January 2020.

The company said that it was incorporating a joint venture in Macau, Hong Kong and Mainland China, with the company’s first store opening at Yansha Outlet, Beijing in November 2019.

The contract with Sojitz Infinity Inc. was concluded in October 2019 which created a retail licence for Japan for five years. The new product licence contract was signed with Next Plc in August 2019 to speed up the growth of the company’s children wear collections. The company opened three quick-term leases in the UK at Lakeside, Stratford, and Cardiff, all with positive starts.

TED – Share Price Performance

On 03rd January 2020 as at 09:57 AM GMT, the TED share price was trading at GBX 422.60 per share on the London Stock Exchange, a decrease of 2.36 per cent or GBX 10.20 per share, versus previous day’s closing price of GBX 432.80 per share.

The share price of GBX 2,129.94 was the 52-week peak price as on 09th January 2019, whereas the share price of GBX 257.60 was the 52-week low share price as on 10th December 2019. The current share price was lower by 80.15 per cent from the 52-week high price, whereas it was higher by 64.05 per cent from the 52-week low price.

The company’s market capitalisation was reported at GBP 181.83 million at the time of writing. The free float and share outstanding of the TED were reported at 28.60 million and 44.57 million, respectively.

While writing, the beta of the TED share was stated at 0.92, which shows lower volatility as compared to the benchmark market index’s movement.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK